YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Key Points Interested in Hyperfine, Inc.? Here are five stocks we like better. Revenue and system sales accelerated: Second-quarter revenue rose 45% year over year to $3.9 million, with 12 systems sold versus eight a year earlier. First-ha…
Glaukos (GKOS) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items. This quarte…
mri scanner ©liz west Shares of Hyperfine (NASDAQ:HYPR) gained 4% in premarket trading on Tuesday after the company announced that it is expected to be added to both the Russell 3000 Index and the Russell 2000 Index. Russell inclusion set…
Hyperfine, Inc. (NASDAQ:HYPR) is one of the top 10 hot penny stocks to buy now. BTIG initiated coverage of Hyperfine, Inc. (NASDAQ:HYPR) with a Buy rating on April 29, setting a price target of $2 and telling investors in a research note t…
A few weeks ago, a research paper out of MIT (the college) crossed my desk that most investors would have ignored. It was about worms. Specifically, it was about a team that had successfully mapped the entire brain of a microscopic worm —…
Image source: The Motley Fool. Date Wednesday, March 18, 2026 at 4:30 p.m. ET Call participants President and Chief Executive Officer — Maria Sainz Chief Administrative Officer and Chief Financial Officer — Brett Hale Host — Webb Campbell…
Earnings Call Insights: Hyperfine, Inc. (HYPR) Q4 2025 MANAGEMENT VIEW * CEO Maria Sainz reported "fourth quarter revenue of over $5 million demonstrated our very strong performance with the next-generation Swoop system for the second stra…
Earnings Call Insights: Hyperfine, Inc. (HYPR) Q3 2025 MANAGEMENT VIEW * Maria Sainz, CEO, announced that the third quarter marked an important new beginning for Hyperfine, citing the launches of the next-generation swoop system and Opti A…
Image source: The Motley Fool. Date Thursday, November 13, 2025 at 4:30 p.m. ET Call participants President and Chief Executive Officer — Maria Sainz Chief Administrative Officer and Chief Financial Officer — Brett Hale Investor Relations…
(RTTNews) - Several small-cap healthcare and biotech names posted notable price increases in after-hours trading on Wednesday, following earnings updates or ahead of scheduled financial disclosures. MacroGenics, Inc. (MGNX) rose 10.2% to $…
Health care stocks fell late Thursday afternoon with the NYSE Health Care Index down 0.2% and the He PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
* Hyperfine (NASDAQ:HYPR [https://seekingalpha.com/symbol/HYPR]) said on Wednesday its preliminary third-quarter revenue is expected to rise about 27% sequentially to $3.4 million, driven by strong demand for its next-generation Swoop port…
As the U.S. stock market sees fluctuations with major indices like the S&P 500 and Nasdaq hitting new records, investors are increasingly exploring diverse investment opportunities. Penny stocks, despite their old-fashioned name, remain a…
Hyperfine reported second quarter 2025 results on Aug. 13, highlighting $2.7 million in revenue for the first half of the year, a 26% sequential increase, and the sale of eight systems in the second quarter. Hyperfine(NASDAQ:HYPR) achieved…
Earnings Call Insights: Hyperfine, Inc. (HYPR) Q2 2025 MANAGEMENT VIEW * CEO Maria Sainz stated that "in the second quarter of 2025, we delivered revenue of $2.7 million up 26% sequentially with the sale of 8 systems, including the sale of…
Image source: The Motley Fool. DATE Aug. 13, 2025 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Maria Sainz Chief Administrative Officer and Chief Financial Officer — Brett Hale Vice President, Investor Relation…
Hyperfine Inc (NASDAQ:HYPR [https://www.chartmill.com/stock/quote/HYPR/profile]) reported its second-quarter 2025 financial results, delivering mixed performance relative to analyst expectations. The company, known for its AI-powered porta…
* Hyperfine press release [https://seekingalpha.com/pr/20200154-hyperfine-inc-reports-second-quarter-2025-financial-results] (NASDAQ:HYPR [https://seekingalpha.com/symbol/HYPR]): Q2 GAAP EPS of -$0.12 in-line. * Revenue of $2.7M (-25.6% Y/…
Investing.com -- Hyperfine, Inc. (NASDAQ:HYPR) stock climbed 4.6% following the announcement of promising early results from its CARE PMR study presented at the 2025 Alzheimer’s Association International Conference in Toronto. The health t…
As the U.S. stock market experiences fluctuations with major indices like the S&P 500 retreating from record highs, investors are keenly observing potential opportunities amid strong corporate earnings and economic data. Penny stocks, ofte…
GUILFORD, Conn. - Hyperfine, Inc. (NASDAQ:HYPR) announced Thursday the first commercial sales of its next-generation Swoop portable MRI system to two hospitals in the northeastern United States. The sales come shortly after the system rece…
B. Riley analyst Yuan Zhi reiterates a Buy rating on Hyperfine (HYPR) with a $1 price target after the company’s premium Swoop received FDA 510k approval weeks ahead of schedule. The new next-generation MRI system includes a new scanner an…
GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain…
NeuroPace, Inc. Preliminary unaudited revenue expected to be between $21.0 million and $21.5 million for Q4 2024, and between $79.4 million and $79.9 million for full year 2024 Scott Huennekens Appointed to NeuroPace Board of Directors eff…
R. Scott Huennekens (Photo: Business Wire)John R. Chiminski (Photo: Business Wire) Veteran Healthcare CEOs John R. Chiminski and R. Scott Huennekens Bring Deep Industry Experience, Operational Expertise and Financial Acumen to the QuidelOr…
BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today anno…
22nd Century Group, Inc Turnaround Veteran to Focus on Unlocking Shareholder Value in Tobacco Assets BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnolog…
GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance…
GUILFORD, Conn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care MRI system, today announced…
GUILFORD, Conn., May 11, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care MRI system, today announced f…
GUILFORD, Conn., April 20, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system™, today announced that it will…
GUILFORD, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system™ today announced fourth quarter…
GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system, today announced that it will r…
GUILFORD, Conn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable MRI system, today announced the U.S. Food a…
GUILFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable MRI system, today announced CE Marking for…
GUILFORD, Conn., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc., the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) device for imaging of the…